Product Program year 2020 Source: CMS Open Payments

Z-Bum

Drug Rash

NDC 58809-375-04

Open in the dashboard

General payments

$801

4 payments

Research payments

0 payments

Through program year 2020, $801 in general payments and $0 in research payments were reported against Z-Bum (Rash).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row

Year	Kind	Amount	Payments
2020	General	$801	4

Breakdown

Who paid General payments · program year 2020

GM Pharmaceuticals, Inc. $801 4 payments

Top recipients General payments · program year 2020

Eduardo Valdes Family Medicine · Dallas, TX $300 37% · 1 payment
Livania Zavala-Spinetti Pediatrics · Edinburg, TX $198 25% · 1 payment
Rosa Manrique Family Medicine · Raymondville, TX $163 20% · 1 payment
Gilberto Gomez Pediatrics · El Paso, TX $140 18% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020

Family Medicine $463 58% · 2 practitioners
Pediatrics $338 42% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020

Texas $801 100% · 4 recipients

Each share is of general payments naming this product in 2020 where a state was reported.

Records

4 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.